InvestorsHub Logo
Post# of 252502
Next 10
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 232008

Monday, 11/16/2020 5:33:33 PM

Monday, November 16, 2020 5:33:33 PM

Post# of 252502
FDA_unable_to_meet_BMY’s_liso-cell_PDUFA_date—(today)—due_to_COVID:

https://finance.yahoo.com/news/bristol-myers-squibb-provides-regulatory-212100907.html

The FDA was unable to conduct an inspection of a third-party manufacturing facility in Texas during the current review cycle due to travel restrictions related to the COVID-19 pandemic. Therefore, the FDA is deferring action on the application until the inspection can be completed. The application remains under review. The FDA did not provide a new anticipated action date.

BMY’s CELG-related CVR (#msg-145844551) is tanking again in AH trading.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.